Brolucizumab-dbll injection is used to treat neovascular (wet) age-related macular degeneration (AMD). Reference standards of Brolucizumab API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Brolucizumab
Catalogue No.:PA 02 2500000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
